Rice researchers build dye-free molecular atlas of Alzheimer’s brain in animal model

사실 확인됨

Rice University scientists say they have created the first complete, label-free molecular atlas of an Alzheimer’s brain in an animal model, combining hyperspectral Raman imaging with machine learning to map chemical changes that appear unevenly across brain regions and extend beyond amyloid plaques.

Scientists at Rice University report they examined brain tissue from both healthy animals and animals with Alzheimer’s disease to create a label-free molecular atlas of the brain.

To do that, the team used hyperspectral Raman imaging, a laser-based method that detects the chemical “fingerprints” of molecules. Because the approach is label-free, the tissue samples were not treated with dyes, fluorescent proteins or molecular tags, the researchers said.

“Traditional Raman spectroscopy takes one measurement of chemical information per molecular site,” said Ziyang Wang, an electrical and computer engineering doctoral student at Rice and a first author of the study. “Hyperspectral Raman imaging repeats this measurement thousands of times across an entire tissue slice to build a full map. The result is a detailed picture showing how chemical composition varies across different regions of the brain.”

The researchers said they mapped whole brains slice by slice, collecting thousands of overlapping spectra to generate high-resolution molecular maps of healthy and diseased tissue.

To analyze the large volume of imaging data, the team applied machine-learning methods, first using unsupervised approaches to identify patterns in molecular signals and then supervised models trained on known Alzheimer’s and non-Alzheimer’s samples to gauge how strongly different brain regions reflected Alzheimer’s-related chemistry.

“We found that the changes caused by Alzheimer’s disease are not spread evenly across the brain,” Wang said. “Some regions show strong chemical changes, while others are less affected. This uneven pattern helps explain why symptoms appear gradually and why treatments that focus on only one problem have had limited success.”

According to the researchers, the results suggest Alzheimer’s-related chemical changes are not confined to amyloid plaques and include broader metabolic differences. They reported that cholesterol and glycogen levels varied across regions, with the largest contrasts in memory-linked areas including the hippocampus and cortex.

“Cholesterol is important for maintaining brain cell structure, and glycogen serves as a local energy reserve,” said Shengxi Huang, an associate professor at Rice and a corresponding author of the study. “Together, these findings support the idea that Alzheimer’s involves broader disruptions in brain structure and energy balance, not only protein buildup and misfolding.”

The study was published in ACS Applied Materials and Interfaces. The research was supported by the National Science Foundation, the National Institutes of Health and the Welch Foundation, the Rice University release said.

Wang said the effort began with measurements from small areas of brain tissue and later expanded to full-brain mapping after multiple rounds of testing to integrate the measurements and analysis.

관련 기사

Scientific illustration showing AI tool SIGNET mapping disrupted gene networks in Alzheimer's brain neurons.
AI에 의해 생성된 이미지

AI tool maps causal gene-control networks in Alzheimer’s brain cells

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Researchers at the University of California, Irvine report that a machine-learning system called SIGNET can infer cause-and-effect links between genes in human brain tissue, revealing extensive rewiring of gene regulation—especially in excitatory neurons—in Alzheimer’s disease.

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

AI에 의해 보고됨 사실 확인됨

Scientists at Northern Arizona University are developing a non-invasive blood test that could help detect Alzheimer’s disease before symptoms appear by examining how the brain uses glucose through tiny blood-borne microvesicles. Led by assistant professor Travis Gibbons and supported in part by the Arizona Alzheimer’s Association, the project aims to enable earlier diagnosis and intervention, similar to how doctors manage cardiovascular disease.

European scientists have developed a preliminary method to identify Alzheimer's using a drop of dried blood from a finger, achieving 86% accuracy in detecting amyloid pathology. The study, validated in 337 patients from several countries, is published in Nature Medicine and aims to simplify early diagnosis of this disease affecting over 50 million people worldwide.

AI에 의해 보고됨

Researchers at UCLA Health and UC San Francisco have identified a natural defense mechanism in brain cells that helps remove toxic tau protein, potentially explaining why some neurons resist Alzheimer's damage better than others. The study, published in Cell, used CRISPR screening on lab-grown human neurons to uncover this system. Findings suggest new therapeutic avenues for neurodegenerative diseases.

Researchers at Sweden’s Karolinska Institutet and Japan’s RIKEN Center for Brain Science report that two somatostatin receptors, SST1 and SST4, jointly regulate levels of neprilysin—an enzyme that breaks down amyloid-beta—in the hippocampus. In mouse models, activating the receptors raised neprilysin, reduced amyloid-beta buildup and improved memory-related behavior, the team said.

AI에 의해 보고됨

Prof KVS Hari, director of the Centre for Brain Research at IISc Bengaluru, emphasized digital biomarkers for early detection and prevention of dementia. He noted that India's rapidly aging population makes dementia a major public health challenge. The centre focuses on data collection and AI to understand disease progression in the Indian context.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부